Literature DB >> 34160714

A multi-conformational virtual screening approach based on machine learning targeting PI3Kγ.

Jingyu Zhu1, Yingmin Jiang2, Lei Jia2, Lei Xu3, Yanfei Cai2, Yun Chen2, Nannan Zhu2, Huazhong Li4, Jian Jin5.   

Abstract

Nowadays, more and more attention has been attracted to develop selective PI3Kγ inhibitors, but the unique structural features of PI3Kγ protein make it a very big challenge. In the present study, a virtual screening strategy based on machine learning with multiple PI3Kγ protein structures was developed to screen novel PI3Kγ inhibitors. First, six mainstream docking programs were chosen to evaluate their scoring power and screening power; CDOCKER and Glide show satisfactory reliability and accuracy against the PI3Kγ system. Next, virtual screening integrating multiple PI3Kγ protein structures was demonstrated to significantly improve the screening enrichment rate comparing to that with an individual protein structure. Last, a multi-conformational Naïve Bayesian Classification model with the optimal docking programs was constructed, and it performed a true capability in the screening of PI3Kγ inhibitors. Taken together, the current study could provide some guidance for the docking-based virtual screening to discover novel PI3Kγ inhibitors.
© 2021. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Keywords:  Isoform-selective; Machine learning; Molecular docking; Naïve Bayesian Classification; PI3Kγ inhibitor; Virtual screening

Mesh:

Substances:

Year:  2021        PMID: 34160714     DOI: 10.1007/s11030-021-10243-1

Source DB:  PubMed          Journal:  Mol Divers        ISSN: 1381-1991            Impact factor:   3.364


  41 in total

Review 1.  Signaling by distinct classes of phosphoinositide 3-kinases.

Authors:  B Vanhaesebroeck; M D Waterfield
Journal:  Exp Cell Res       Date:  1999-11-25       Impact factor: 3.905

2.  Theoretical studies on the selectivity mechanisms of PI3Kδ inhibition with marketed idelalisib and its derivatives by 3D-QSAR, molecular docking, and molecular dynamics simulation.

Authors:  Jingyu Zhu; Ke Ke; Lei Xu; Jian Jin
Journal:  J Mol Model       Date:  2019-07-23       Impact factor: 1.810

3.  Rational Design of Novel Phosphoinositide 3-Kinase Gamma (PI3Kγ) Selective Inhibitors: A Computational Investigation Integrating 3D-QSAR, Molecular Docking and Molecular Dynamics Simulation.

Authors:  Kan Li; Jingyu Zhu; Lei Xu; Jian Jin
Journal:  Chem Biodivers       Date:  2019-06-21       Impact factor: 2.408

4.  Insight into the selective mechanism of phosphoinositide 3-kinase γ with benzothiazole and thiazolopiperidine γ-specific inhibitors by in silico approaches.

Authors:  Jingyu Zhu; Kan Li; Lei Xu; Jian Jin
Journal:  Chem Biol Drug Des       Date:  2019-01-11       Impact factor: 2.817

5.  Discovery of Potent and Selective PI3Kγ Inhibitors.

Authors:  Samuel L Drew; Rhiannon Thomas-Tran; Joel W Beatty; Jeremy Fournier; Kenneth V Lawson; Dillon H Miles; Guillaume Mata; Ehesan U Sharif; Xuelei Yan; Artur K Mailyan; Elaine Ginn; Jie Chen; Kent Wong; Divyank Soni; Puja Dhanota; Pei-Yu Chen; Stefan G Shaqfeh; Cesar Meleza; Amber T Pham; Ada Chen; Xiaoning Zhao; Jesus Banuelos; Lixia Jin; Ulrike Schindler; Matthew J Walters; Stephen W Young; Nigel P Walker; Manmohan Reddy Leleti; Jay P Powers; Jenna L Jeffrey
Journal:  J Med Chem       Date:  2020-09-16       Impact factor: 7.446

Review 6.  Discovery of selective phosphatidylinositol 3-kinase inhibitors to treat hematological malignancies.

Authors:  Jingyu Zhu; Tingjun Hou; Xinliang Mao
Journal:  Drug Discov Today       Date:  2015-04-06       Impact factor: 7.851

Review 7.  Targeting the phosphatidylinositol 3-kinase/AKT pathway for the treatment of multiple myeloma.

Authors:  J Zhu; M Wang; B Cao; T Hou; X Mao
Journal:  Curr Med Chem       Date:  2014       Impact factor: 4.530

8.  Insulin-like growth factor-1 regulates platelet activation through PI3-Kalpha isoform.

Authors:  Soochong Kim; Analia Garcia; Shaun P Jackson; Satya P Kunapuli
Journal:  Blood       Date:  2007-09-07       Impact factor: 22.113

Review 9.  Targeting phosphatidylinositol 3-kinase gamma (PI3Kγ): Discovery and development of its selective inhibitors.

Authors:  Jingyu Zhu; Kan Li; Li Yu; Yun Chen; Yanfei Cai; Jian Jin; Tingjun Hou
Journal:  Med Res Rev       Date:  2020-12-10       Impact factor: 12.944

Review 10.  PI3K inhibitors in inflammation, autoimmunity and cancer.

Authors:  Anne-Katrien Stark; Srividya Sriskantharajah; Edith M Hessel; Klaus Okkenhaug
Journal:  Curr Opin Pharmacol       Date:  2015-06-18       Impact factor: 5.547

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.